A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
NGM Biopharmaceuticals, Inc
BioNTech SE
Taiho Pharmaceutical Co., Ltd.
TG Therapeutics, Inc.
Amgen
Dartmouth-Hitchcock Medical Center
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
CONKO-Studiengruppe